CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume,in Coronary Arteries ( nt and will consult with international ...)

CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume,in Coronary Arteries

nt and will consult with international experts to evaluate next steps."

FORWARD LOOKING STATEMENT

The materials in this presentation speak only as of the date of these materials, and include forward looking statements about our financial results and estimates, business prospects and products in research that involve substantial risks and uncertainties, many of which are outside the control of, and are unknown to, CSL. You can identify these statements by the fact that they use words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," "target," "may," "assume," and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. Among the factors that could cause actual results to differ materially are the following: the success of research and development activities, decisions by regulatory authorities regarding whether and when to approve our drug applications as well as their decisions regarding labeling and other matters that would affect the commercial potential of our products; competitive developments affecting our current growth products; the ability to successfully market new and existing products in Australia and other countries; difficulties or delays in manufacturing; trade buying patterns, fluctuations in interest and currency exchange rates; legislation or regulations throughout the world that affect product production, distribution, pricing, reimbursement or access; legal defense costs, insurance expenses, settlement costs and the risk of an adverse decision or settlement relating to product liability, patent protection or governmental investigations, growth in costs and expenses; and CSL's ability to protect its patents and other intellectual property throughout the world. The statements being made in this presentation do not constitute an offer to sell, or solicitation of an offer to buy, any securities of CSL.

CSL is a global specialty biopha
'"/>

Page: 1 2 3 4
Related medicine technology :

1. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
4. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
5. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
6. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
7. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
8. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
9. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
10. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
11. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes

Post Your Comments:

(Date:3/17/2010)... NEW YORK , March 17 The latest advancement in facial contouring, the AccuLift™ procedure, was just featured on CBS, The Early Show . New York ... ... , ... ...

(Date:3/17/2010)... New York Emerging Growth Institutional Investor Forum at The Grand Hyatt in New York City on Tuesday, March 23, 2010 . , ... , , ... ... ...

(Date:3/17/2010)... Access MediQuip, LLC, the nation,s first and largest provider of outsourced implantable medical device ... Service, "RMS," for its customers nationwide. The new release is designed to protect patients, inform ... ... ...

Breaking Medicine Technology:'The AccuLift Phenomenon' Kicks off on CBS' The Early Show 2 'The AccuLift Phenomenon' Kicks off on CBS' The Early Show 3 Kensey Nash To Participate in the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum 2 Access MediQuip Announces Release of the Country's First Centralized Recall Management Service(SM) for Implantable Devices 2 Access MediQuip Announces Release of the Country's First Centralized Recall Management Service(SM) for Implantable Devices 3 UAB partners seek safe carbon dioxide storage for greener power generation 10663 1 UAB partners seek safe carbon dioxide storage for greener power generation 10663 2 UAB partners seek safe carbon dioxide storage for greener power generation 10663 3 Researchers complete draft genome sequence for cassava 10660 1 Researchers complete draft genome sequence for cassava 10660 2 Researchers complete draft genome sequence for cassava 10660 3 Researchers complete draft genome sequence for cassava 10660 4 Depressed and Pregnant 3F Flu Shot May Be Needed 60976 1 Depressed and Pregnant 3F Flu Shot May Be Needed 60976 2

[0] 'The AccuLift Phenomenon' Kicks off on CBS' The Early Show [0] Kensey Nash To Participate in the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum [0] Access MediQuip Announces Release of the Country's First Centralized Recall Management Service(SM) for Implantable Devices

... for Obstetrician-Gynecologists States UFE Meets Level,A Evidence ... Is Safe, Effective Option for Women With ... The Society of,Interventional Radiology, a national organization ... professionals dedicated to improving health,care through minimally ...

... safety ... profile -, ... ), a biopharmaceutical company engaged,in the discovery and development of drugs ... that it has completed the,proof-of-concept study evaluating IDX899, a non-nucleoside reverse,transcriptase ...

Other Medicine Technology:Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2 Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3 Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2 Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3 Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4

Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients

(Date:3/18/2010)... bloodstream infection risk reduction strategies in PA health facilities are questioned , ... , , ... ... ...

(Date:3/18/2010)... , ... , ... ... WASHINGTON , March 18 S.T.O.P. - Safe Tables Our Priority and victims of foodborne illness called upon the United ...

(Date:3/18/2010)... of Public Health will receive nearly $15 million from ... and modernization of laboratory space at its main facility ... grant was awarded by the National Center for Research ... renovation includes updating labs and new infrastructure in the ...

(Date:3/18/2010)... pregnancy, researcher says , , THURSDAY, March 18 (HealthDay News) -- ... will develop asthma, a new study finds. , The role ... suggest that prenatal stress can influence the infant,s immune system ... that asthma is most prevalent in inner cities, where minorities ...

(Date:3/18/2010)... China , March 18 /PRNewswire-Asia/ -- Earlier this month, http://www.glassesshop.com ("GS"), the world,s leading online eyewear selling,website, launched a themed event before the "Save ... ... , , ... ...

Breaking Medicine News(10 mins):Health News:Studies Show Significant Increases of C. Difficile Infections (CDI) 2 Health News:Studies Show Significant Increases of C. Difficile Infections (CDI) 3 Health News:Studies Show Significant Increases of C. Difficile Infections (CDI) 4 Health News:Studies Show Significant Increases of C. Difficile Infections (CDI) 5 Health News:Studies Show Significant Increases of C. Difficile Infections (CDI) 6 Health News:Studies Show Significant Increases of C. Difficile Infections (CDI) 7 Health News:Victims of Contaminated Meat Call on USDA to Address Deadly Pathogens 2 Health News:Victims of Contaminated Meat Call on USDA to Address Deadly Pathogens 3 Health News:Prenatal Stress May Boost Baby's Asthma Risk 2 Health News:Prenatal Stress May Boost Baby's Asthma Risk 3 Health News:Glassesshop.com Has Launched 'Save Your Vision Week' Themed Event 2

[0] Studies Show Significant Increases of C. Difficile Infections (CDI)[0] Victims of Contaminated Meat Call on USDA to Address Deadly Pathogens [0] Bloomberg School of Public Health awarded $15 million for laboratory renovation and modernization [0] Prenatal Stress May Boost Baby's Asthma Risk [0] Glassesshop.com Has Launched 'Save Your Vision Week' Themed Event

... Reflecting Growth of 27-29 Percent over ... 2007 First-Quarter Year-Over-Year Highlights (adjusted for January ... two-for-one stock split): - ... $0.55 from $0.52, excluding $0.05 in amortization of intangible ...

... benefit: increasing the amount of insulin produced by ... insulin resistance, the first step toward type 2 ... known to reduce blood glucose in diabetic patients. ... of Clinical Endocrinology & Metabolism reveals a similar ...

... Serious Financial Burden Caused By Medical,Bills; 7 Percent Say ... Spouse Could Get Health Benefits, MENLO PARK, Calif., ... personal economic problems, and their,struggles to deal with those ... health care, a new Kaiser Family Foundation,poll finds., ...

... on Wednesday, April 30 at 2 p.m. Eastern -, ... VRML ), a molecular diagnostics company, will host a ... peripheral,artery disease (PAD) and to provide information about the ... The,teleconference will take place on Wednesday, April 30 at ...

... return to work, analysis finds , , MONDAY, April 28 ... surgically implanting an artificial vertebrae onto one,s spine may ... but it saves the patient almost $6,000 within two ... cost savings is primarily from the patient,s ability to ...

... Inscent, Inc. has received a,Small Business ... Science,Foundation (NSF) to continue the testing and ... Attenu high throughput assay system. The,pioneering research ... highly,efficient processes that allow the rapid development ...

Medco Reports Strong First-Quarter Results; Record EPS, Mail-Order Volume, Generic Dispensing Rates Aspirin-like compounds increase insulin secretion in otherwise healthy obese people Americans Rank Health Care Near the Top of Their Economic Woes, New Poll Finds Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program Artificial Cervical Disc Surgery Cheaper Than Fusion Inscent, Inc. Receives Federal Grant to Develop Honeybee Repellents

(1-15 LPM), 50 psi, 1/ 8" NPT female back inlet...

Pediatric (1/10-1 LPM), 50 psi back inlet, wall mounted, 1/8" NPT female....

... flowmeters., ,Options: , For ... to model number. Example: FMC107S. ... suffix C to model number. ... Flowmeters with Power Take-Off, add ...

Value-Line oxygen flowmeters. ,Options: , For security chain, add suffix S to model number. Example: FMQ107S. , For Canadian Color-Code, add suffix FMQ104C. , For Double Flowmeters with Power Take-Of...

Medicine Products:

Oxygen Flowmeter (Cylindrical Style)Pediatric Oxygen Flowmeter (Block Style)Click Style Oxygen Power Take Off Flowmeters Value-Line Oxygen Flowmeters

( nt and will consult with international ...)CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume,in Coronary Arteries,Health